Surgical Science Sweden AB (publ) (SUSRF)
SUSRF Stock Price Chart
Explore Surgical Science Sweden AB (publ) interactive price chart. Choose custom timeframes to analyze SUSRF price movements and trends.
SUSRF Company Profile
Discover essential business fundamentals and corporate details for Surgical Science Sweden AB (publ) (SUSRF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
21 Jan 2021
Employees
274.00
Website
https://www.surgicalscience.comCEO
Tom Englund
Description
Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence-based laparoscopic and endoscopic training. It offers LapSim training system comprising LapSim ST develops to train surgical technologists and surgical assistants; and LapSim essence, a portable and ready-to-use VR simulator. The company also provides EndoSim system, an endoscopy simulator that delivers medical simulation training; TeamSim, a dynamic platform for inter-professional education development taking surgery simulation into the real world teamwork; Simball Box, which offers feedback on velocity with tutorial task videos showing a preferred approach; simbionix simulators; and robotic surgery simulators. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden.
SUSRF Financial Timeline
Browse a chronological timeline of Surgical Science Sweden AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 19 Feb 2026
Upcoming earnings on 13 Nov 2025
Revenue estimate is $282.50M.
Earnings released on 21 Aug 2025
EPS came in at -$0.04 falling short of the estimated $0.08 by -152.70%, while revenue for the quarter reached $22.01M , missing expectations by -92.31%.
Earnings released on 14 May 2025
EPS came in at $0.65 surpassing the estimated $0.04 by +1.39K%, while revenue for the quarter reached $250.69M , missing expectations by -3.70%.
Earnings released on 19 Feb 2025
EPS came in at $0.71 surpassing the estimated $0.09 by +696.19%, while revenue for the quarter reached $251.55M , missing expectations by -3.77%.
Earnings released on 14 Nov 2024
EPS came in at $0.84 surpassing the estimated $0.07 by +1.07K%, while revenue for the quarter reached $231.83M , missing expectations by -12.77%.
Earnings released on 22 Aug 2024
EPS came in at $0.56 surpassing the estimated $0.07 by +731.23%, while revenue for the quarter reached $212.47M , beating expectations by +934.22%.
Earnings released on 15 May 2024
EPS came in at $0.47 surpassing the estimated $0.08 by +468.17%, while revenue for the quarter reached $188.24M , beating expectations by +799.25%.
Earnings released on 21 Feb 2024
EPS came in at $1.92 surpassing the estimated $0.12 by +1.52K%, while revenue for the quarter reached $227.29M , beating expectations by +758.32%.
Earnings released on 30 Sept 2023
EPS came in at $0.93 surpassing the estimated $0.06 by +1.35K%, while revenue for the quarter reached $210.25M , beating expectations by +936.81%.
Earnings released on 30 Jun 2023
EPS came in at $0.76 surpassing the estimated $0.07 by +985.32%, while revenue for the quarter reached $216.24M , beating expectations by +930.32%.
Earnings released on 31 Mar 2023
EPS came in at $0.98 surpassing the estimated $0.05 by +1.85K%, while revenue for the quarter reached $229.08M , beating expectations by +1.15K%.
Earnings released on 22 Feb 2023
EPS came in at $2.29 surpassing the estimated $0.82 by +179.27%, while revenue for the quarter reached $250.11M , beating expectations by +1.03K%.
Earnings released on 10 Nov 2022
EPS came in at $0.56 falling short of the estimated $0.63 by -11.11%, while revenue for the quarter reached $205.08M , beating expectations by +1.08K%.
Earnings released on 25 Aug 2022
EPS came in at $0.52 surpassing the estimated $0.50 by +4.00%, while revenue for the quarter reached $188.22M , beating expectations by +1.07K%.
Earnings released on 11 May 2022
EPS came in at $0.32 falling short of the estimated $0.40 by -20.00%, while revenue for the quarter reached $159.14M , beating expectations by +881.31%.
Earnings released on 16 Feb 2022
EPS came in at $1.31 surpassing the estimated $0.55 by +138.18%, while revenue for the quarter reached $197.69M , beating expectations by +1.03K%.
Earnings released on 10 Nov 2021
EPS came in at $0.33 surpassing the estimated $0.20 by +65.00%, while revenue for the quarter reached $95.32M .
Earnings released on 20 Aug 2021
EPS came in at $0.09 falling short of the estimated $0.15 by -40.00%, while revenue for the quarter reached $36.56M .
Earnings released on 11 May 2021
EPS came in at $0.04 falling short of the estimated $0.07 by -42.86%, while revenue for the quarter reached $37.20M .
Earnings released on 11 Feb 2021
EPS came in at $0.31 matching the estimated $0.31, while revenue for the quarter reached $39.60M .
Earnings released on 5 Nov 2020
EPS came in at $0.17 surpassing the estimated $0.08 by +112.50%, while revenue for the quarter reached $24.93M .
SUSRF Stock Performance
Access detailed SUSRF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.